Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC).

被引:5
作者
Wang, Emilie
Kim, Dae Won
Mahipal, Amit
Chen, Dung-Tsa
Cao, Biwei
Masawi, Fadzai
Kim, Richard D.
机构
[1] Univ S Florida, Tampa, FL USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
D O I
10.1200/JCO.2019.37.4_suppl.431
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
431
引用
收藏
页数:2
相关论文
empty
未找到相关数据